相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
Tanmoy Mondal et al.
CANCER CELL (2018)
Spontaneous regression of neuroblastoma
Garrett M. Brodeur
CELL AND TISSUE RESEARCH (2018)
Molecular mechanisms and therapeutic targets in neuroblastoma
John Inge Johnsen et al.
PHARMACOLOGICAL RESEARCH (2018)
The Expanding World of N-MYC-Driven Tumors
David S. Rickman et al.
CANCER DISCOVERY (2018)
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
Noemie Braekeveldt et al.
CANCER RESEARCH (2018)
Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor
Flora Cimmino et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
From Neural Crest Development to Cancer and Vice Versa: How p75NTR and (Pro)neurotrophins Could Act on Cell Migration and Invasion?
Sabine Wislet et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Too many targets, not enough patients: rethinking neuroblastoma clinical trials
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2018)
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
Lucas Moreno et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Advances in emerging drugs for the treatment of neuroblastoma
Pablo Berlanga et al.
EXPERT OPINION ON EMERGING DRUGS (2017)
Overview and recent advances in the treatment of neuroblastoma
Sarah B. Whittle et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Irinotecan-temozolomide with temsirolimus or dinutuximab Crosstafark in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
Rajen Mody et al.
LANCET ONCOLOGY (2017)
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2017)
MYCN induces neuroblastoma in primary neural crest cells
R. R. Olsen et al.
ONCOGENE (2017)
Rho-associated kinase is a therapeutic target in neuroblastoma
Cecilia Dyberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Neuroblastoma
Jason Shohet et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Neuroblastoma
Jason Shohet et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Neuroblastoma treatment in the post-genomic era
Maria Rosaria Esposito et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities
Roodolph St. Pierre et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
Kristopher R. Bosse et al.
CANCER (2016)
The role of the ALK receptor in cancer biology
B. Hallberg et al.
ANNALS OF ONCOLOGY (2016)
The SWI/SNF BAF-A complex is essential for neural crest development
Ronald L. Chandler et al.
DEVELOPMENTAL BIOLOGY (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
Robert W. Schnepp et al.
CANCER CELL (2015)
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
Mike R. Russell et al.
CANCER RESEARCH (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Derek A. Oldridge et al.
NATURE (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm et al.
NATURE GENETICS (2015)
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Linda J. Valentijn et al.
NATURE GENETICS (2015)
Neuroblastoma Paradigm for Precision Medicine
Meredith S. Irwin et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
K. Althoff et al.
ONCOGENE (2015)
Genotype-Phenotype Correlation of Coffin-Siris Syndrome Caused by Mutations in SMARCB1, SMARCA4, SMARCE1, and ARID1A
Tomoki Kosho et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2014)
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
Gaurav Kumar Pandey et al.
CANCER CELL (2014)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
Mario Capasso et al.
CANCER RESEARCH (2014)
Insight into planar cell, polarity
Michael Sebbagh et al.
EXPERIMENTAL CELL RESEARCH (2014)
Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database
Daniel A. Morgenstern et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Mechanisms of neuroblastoma regression
Garrett M. Brodeur et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer
Alberto L'Abbate et al.
NUCLEIC ACIDS RESEARCH (2014)
Long-Term Results of the Combination of the N7 Induction Chemotherapy and the Busulfan-Melphalan High Dose Chemotherapy
Dominique Valteau-Couanet et al.
PEDIATRIC BLOOD & CANCER (2014)
Suppression of Cpn10 Increases Mitochondrial Fission and Dysfunction in Neuroblastoma Cells
So Jung Park et al.
PLOS ONE (2014)
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
Alex Cazes et al.
ONCOTARGET (2014)
The prenatal origins of cancer
Glenn M. Marshall et al.
NATURE REVIEWS CANCER (2014)
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
Mario Capasso et al.
CARCINOGENESIS (2013)
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients A SIOPEN phase 1 study
Ruth Ladenstein et al.
MABS (2013)
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Mark Sausen et al.
NATURE GENETICS (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Boundary formation in the development of the vertebrate hindbrain
Qiling Xu et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Teeara Berry et al.
CANCER CELL (2012)
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Shizhen Zhu et al.
CANCER CELL (2012)
Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
Kristopher R. Bosse et al.
CANCER RESEARCH (2012)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Melanoma genome sequencing reveals frequent PREX2 mutations
Michael F. Berger et al.
NATURE (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Sharon J. Diskin et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
Essential Roles of Gangliosides in the Formation and Maintenance of Membrane Microdomains in Brain Tissues
Yuhsuke Ohmi et al.
NEUROCHEMICAL RESEARCH (2012)
Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
Agnes Rasmuson et al.
PLOS ONE (2012)
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Lukas C. Heukamp et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Rare Copy Number Variations in Adults with Tetralogy of Fallot Implicate Novel Risk Gene Pathways
Candice K. Silversides et al.
PLOS GENETICS (2012)
Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
Makoto Yanagisawa et al.
ASN NEURO (2011)
The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma
Peng Huang et al.
CANCER RESEARCH (2011)
Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Elena Piskounova et al.
CELL (2011)
Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition
Tobias Reiff et al.
DEVELOPMENT (2011)
Transcriptional control of differentiation and neurogenesis in autonomic ganglia
Hermann Rohrer
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Integrative genomics identifies LMO1 as a neuroblastoma oncogene
Kai Wang et al.
NATURE (2011)
Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
C. Hahmann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Neuroblastoma: Biology, Prognosis, and Treatment
Julie R. Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Neuroblastoma Phox2b Variants Stimulate Proliferation and Dedifferentiation of Immature Sympathetic Neurons
Tobias Reiff et al.
JOURNAL OF NEUROSCIENCE (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription
Liling Tang et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2010)
Embryonal neural tumours and cell death
John Inge Johnsen et al.
APOPTOSIS (2009)
Anaplastic lymphoma kinase: signalling in development and disease
Ruth H. Palmer et al.
BIOCHEMICAL JOURNAL (2009)
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
P. F. Ambros et al.
BRITISH JOURNAL OF CANCER (2009)
On Trk-The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
Carol J. Thiele et al.
CLINICAL CANCER RESEARCH (2009)
Trk Receptor Expression and Inhibition in Neuroblastomas
Garrett M. Brodeur et al.
CLINICAL CANCER RESEARCH (2009)
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J. Diskin et al.
NATURE (2009)
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso et al.
NATURE GENETICS (2009)
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
Andrew D. J. Pearson et al.
LANCET ONCOLOGY (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment
Agnieszka Rybak et al.
NATURE CELL BIOLOGY (2008)
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
John M. Maris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing
Martin A. Newman et al.
RNA (2008)
Selective blockade of MicroRNA processing by Lin28
Srinivas R. Viswanathan et al.
SCIENCE (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Characterization of the expression of the ALK receptor tyrosine kinase in mice
E Vernersson et al.
GENE EXPRESSION PATTERNS (2006)
Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system
SP Hurley et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group
WB London et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system
AM Goldstein et al.
MECHANISMS OF DEVELOPMENT (2005)
Mechanisms of embryonal tumor initiation:: Distinct roles for MycN expression and MYCN amplification
LM Hansford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A systematic review of molecular and biological tumor markers in neuroblastoma
RD Riley et al.
CLINICAL CANCER RESEARCH (2004)
Two related ARID family proteins are alternative subunits of human SWI/SNF complexes
XM Wang et al.
BIOCHEMICAL JOURNAL (2004)
Essential role of Gata transcription factors in sympathetic neuron development
K Tsarovina et al.
DEVELOPMENT (2004)
Ephs and ephrins during early stages of chick embryogenesis
RK Baker et al.
DEVELOPMENTAL DYNAMICS (2003)
Rocks: Multifunctional kinases in cell behaviour
K Riento et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Neuroblastoma screening at one year of age
FH Schilling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons
K Wartiovaara et al.
JOURNAL OF NEUROSCIENCE (2002)
Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway
K Wong et al.
CELL (2001)
分享论文
